Merit Financial Group »

Compass Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $52k 24k 2.19

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Apple Put Option (AAPL)
Gmo Etf Trust Us Quality Etf (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Isha In Ctry Etf (CORO)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Merit Financial Group

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Adage Capital Partners GP
Enavate Sciences GP
BVF
State Street Corporation
Vanguard Capital Management
Rtw Investments
Deerfield Management Company
Geode Capital Management
Rock Springs Capital Management
Logos Global Management

View all funds holding Compass Therapeutics